awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38584336-EA9709EC-7100-485B-87CB-57371F15D708
Q38584336-EA9709EC-7100-485B-87CB-57371F15D708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38584336-EA9709EC-7100-485B-87CB-57371F15D708
The use of bisphosphonates in women: when to use and when to stop.
P2860
Q38584336-EA9709EC-7100-485B-87CB-57371F15D708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38584336-EA9709EC-7100-485B-87CB-57371F15D708
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5dbec5a1b99d41d0aeba95b166003da6cdd52874
P2860
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.